Antibody Drug Discovery

With their exceptional specificity, precise targeting, and demonstrated clinical benefit, antibody therapeutics has become as one of the most influential modalities in biopharma. Global approvals continue to rise, fueling rapid market growth. In this new wave, emerging antibody drug discovery technologies and platforms create unprecedented opportunities—while raising the bar for selecting the right development partner.

As a trusted partner, ChemExpress offers integrated early-stage antibody drug discovery services, encompassing monoclonal, bispecific, and multispecific antibodies, recombinant proteins, and antibody-drug conjugates (ADCs), enabling faster, higher-quality candidate selection.

图片描述1

One-Stop Biologics
CDMO Service

We offer comprehensive, full lifecycle solutions encompassing monoclonal, bispecific, and multispecific antibodies, recombinant proteins, and ADCs, building an integrated service platform that covers the entire process from R&D to commercialization.

图片描述3

Expert Scientific
Team

Our team of over 200 scientists provides comprehensive support from R&D to commercialization, enabling efficient scale-up and seamless technology transfer,effectively reducing management and transition costs. 

图片描述2

Flexible & Efficient
Capabilities

We are equipped with reactor scales of 200L, 500L, and 2,000L, as well as precision instruments such as high-resolution mass spectrometers. Our production capabilities support all stages of drug development (Non-GMP & cGMP). 

Our Services

ChemExpress offers antibody drug discovery, spanning antibody sample preparation, developability assessment and in vitro efficacy assessment, assisting in the selection of the most suitable candidate antibodies for your drug development program.

Our Service Scope Includes

  • Sample Preparation: transient expression & stable expression
  • Developability Assessment: solubility/aggregation liability, viscosity, thermal/colloidal stability
  • In Vitro Efficacy Assessment

Equipment

Our Sites

R&D & Manufacturing Site

研发图片1
Chongqing ADC CDMO Manufacturing Site
Monoclonal, Bispecific, and Multispecific Antibodies, Recombinant
proteins, and ADCs Process Development & Manufacturing

FAQs

We have recently been working on the preparation of bispecific antibody samples for the PCC stage, with experience in 6 bispecific antibody ADC projects so far. Most of the R&D and production team members also have experience with bispecific antibodies.

Request for Information

  • Please enter first Name.
    Please enter last Name.
  • Please enter email address.
  • Please enter company address.
    Please enter the correct captcha.
Please check agree.